Medicare Enrolled

Dr. Lindsey Finklea, M.D.

Dermatology · San Antonio, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
10603 WEST AVE, San Antonio, TX 78213
2109019353
In practice since 2009 (16 years)
NPI: 1528294055 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Finklea from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Finklea? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Finklea

Dr. Lindsey Finklea is a dermatology specialist in San Antonio, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Finklea performed 4,062 Medicare services across 1,822 unique beneficiaries.

Between the years covered by Open Payments, Dr. Finklea received a total of $259,051 from 56 pharmaceutical and/or device companies across 1509 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Finklea is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 30% volume in TX $259,051 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,062
Medicare services
Top 30% in TX for dermatology
1,822
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~254 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14 1,438 $5 $11
Office visit, established patient (20-29 min) 402 $58 $116
Destruction of precancerous skin growth, 1 390 $30 $109
Destruction of skin growths (warts/lesions), 1-14 346 $75 $164
Office visit, established patient (30-39 min) 222 $79 $184
Ultrasonic guidance for placement of radiation therapy fields 209 $136 $250
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area 204 $202 $450
Superficial and/or low voltage radiation treatment delivery 197 $31 $56
Skin biopsy, tangential 169 $55 $147
New patient office visit (30-44 min) 74 $65 $170
Biopsy of related skin growth, each additional growth 73 $38 $72
Steroid injection (triamcinolone) 67 $1 $6
New patient office visit (45-59 min) 63 $98 $243
Drug injection, under skin or into muscle 47 $9 $32
Destruction of precancer skin growth, 15 or more growths 36 $114 $225
Simple or single drainage of skin abscess 22 $71 $183
Injection into skin growth, 1-7 growths 21 $36 $65
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm 21 $193 $433
Punch biopsy, first skin growth 17 $89 $175
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm 17 $89 $329
Office visit, established patient (10-19 min) 14 $39 $74
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm 13 $119 $244
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$259,051
Total received (2018-2024)
Avg $37,007/year across 7 years
Top 4% in TX for dermatology
56
Companies
1,509
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$123,681 (47.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$114,001 (44.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,370 (8.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$51,303
2023
$58,663
2022
$67,365
2021
$19,308
2020
$6,645
2019
$51,507
2018
$4,261

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$70,518
Regeneron Healthcare Solutions, Inc.
$41,551
Lilly USA, LLC
$41,118
Novartis Pharmaceuticals Corporation
$31,341
UCB, Inc.
$11,911
GENZYME CORPORATION
$11,585
EPI Health, LLC
$7,367
NOVARTIS PHARMACEUTICALS CORPORATION
$6,444
E.R. Squibb & Sons, L.L.C.
$5,232
Ortho Dermatologics, a division of Bausch Health US, LLC
$4,189
PFIZER INC.
$4,075
AbbVie Inc.
$3,117
Galderma Laboratories, L.P.
$2,860
Janssen Biotech, Inc.
$2,776
LEO Pharma Inc.
$2,647
Genentech USA, Inc.
$1,974
Journey Medical Corporation
$1,196
Almirall LLC
$1,016
Incyte Corporation
$898
Dermavant Sciences, Inc.
$805
Amgen Inc.
$801
AbbVie, Inc.
$725
Sun Pharmaceutical Industries Inc.
$550
Allergan Inc.
$467
Biofrontera Inc.
$463
VYNE Pharmaceuticals Inc.
$455
Arcutis Biotherapeutics, Inc.
$263
Mayne Pharma Inc.
$248
SUN PHARMACEUTICAL INDUSTRIES INC.
$234
Celgene Corporation
$202
REVANCE THERAPEUTICS, INC.
$198
Encore Dermatology Inc.
$191
SANOFI-AVENTIS U.S. LLC
$171
Allergan, Inc.
$171
Janssen Scientific Affairs, LLC
$165
Merz North America, Inc.
$146
Paratek Pharmaceuticals, Inc.
$138
Boehringer Ingelheim Pharmaceuticals, Inc.
$122
GlaxoSmithKline, LLC.
$108
Tactile Systems Technology Inc
$106
Mylan Pharmaceuticals Inc.
$73
KCI USA, Inc
$62
Taro Pharmaceuticals USA, Inc.
$50
Glenmark Therapeutics Inc.
$49
Promius Pharma LLC
$38
PruGen, Inc. Pharmaceuticals
$35
MAYNE PHARMA INC.
$31
Sandoz Inc.
$22
Aclaris Therapeutics, Inc.
$22
DERMIRA, INC.
$22
Organogenesis Inc.
$21
AstraZeneca Pharmaceuticals LP
$18
Mission Pharmacal Company
$17
Helsinn Therapeutics (U.S.), Inc.
$16
Medimetriks Pharmaceuticals, Inc.
$16
Merck Sharp & Dohme Corporation
$14
Top 3 companies account for 59.1% of total payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADAPTIC · ADBRY · AKLIEF · AMELUZ · AMZEEQ · Absorica LD · Acticlate · Aczone · Ameluz · Amnesteem · BENLYSTA · BLU-U · BOTOX · BOTOX COSMETIC · BRYHALI · Bimzelx · CIBINQO · CLODERM · COSENTYX · Ceracade · Cimzia · Clindacin ETZ · Clindamycin Phosphate and Benzoyl Peroxide · Cordran · DAXXIFY · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Ecoza · Enbrel · Erivedge · Exelderm · FLEXITOUCH · Flexitouch Plus · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · ILUMYA · Impoyz · JUBLIA · KERYDIN · Klisyri · LIBTAYO · Mupirocin Cream · NUZYRA · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Odomzo · Olux · Otezla · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SAPHNELO · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Sernivo Spray · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · TWYNEO · TargaDox · Tremfya · Trianex · ULTRAVATE · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · VALCHLOR · VTAMA · Veltin · Winlevi · XELJANZ · XEOMIN · XOLAIR · Xolair · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (48%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for dermatology in TX.

Equivalent to $6,377 per 100 Medicare services performed
Looking for a dermatology specialist in San Antonio?
Compare dermatologists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
109
Per 100K population
5.4
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
3.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Finklea is a clinical cardiology specialist, with above-average Medicare volume (top 30% in TX), with consulting-driven industry engagement in the top 4% of TX peers, with 16 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Finklea experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Finklea performed 1,438 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Finklea receive payments from pharmaceutical companies?
Yes. Dr. Finklea received a total of $259,051 from 56 companies across 1,509 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Finklea's costs compare to other dermatologists in San Antonio?
Dr. Finklea's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Finklea) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →